US 12173062
Modified TNF-α antibodies and uses thereof
granted A61KA61K38/2013A61K47/6813
Quick answer
US patent 12173062 (Modified TNF-α antibodies and uses thereof) held by Bright Peak Therapeutics AG expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Bright Peak Therapeutics AG
- Grant date
- Tue Dec 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K38/2013, A61K47/6813, A61K47/6845, A61P